The kynurenine pathway of tryptophan degradation as a drug target.
In mammalian cells, the essential amino acid tryptophan is degraded primarily by the kynurenine pathway, a cascade of enzymatic steps containing several biologically active compounds. Metabolites of this pathway, collectively termed 'kynurenines', have been shown to be involved in many diverse physiological and pathological processes. In particular, fluctuations in the levels of kynurenines have discrete effects on the nervous and immune systems. A considerable number of pharmacological tools have recently become available to probe the kynurenine pathway experimentally. Some of these 'kynurenergic' agents can be envisioned to be of therapeutic value, especially in the treatment of diseases that are associated with impaired kynurenine pathway metabolism.
Schwarcz
Robert
R
Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, Maryland 21228, USA. rschwarc@mprc.umaryland.edu
D000818:Animals; D006801:Humans; D007737:Kynurenine / Q000096:biosynthesis / Q000187:drug effects* / Q000627:therapeutic use; D008660:Metabolism / Q000187:drug effects*; D014364:Tryptophan / Q000378:metabolism*
D007737:Kynurenine; D014364:Tryptophan